Viewing Study NCT04503967


Ignite Creation Date: 2025-12-25 @ 12:40 AM
Ignite Modification Date: 2025-12-25 @ 10:51 PM
Study NCT ID: NCT04503967
Status: UNKNOWN
Last Update Posted: 2020-08-07
First Post: 2020-08-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy and Safety of Anlotinib Hydrochloride Combined With Nivolumab in the Treatment of Gastric and Esophageal Cancer
Sponsor: Shanghai Zhongshan Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module References Module